3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other
1
Gynecologic
1
Gastrointestinal
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
19
Triple Negative Breast Neoplasms
2
Cardiotoxicity
2
Ovarian Neoplasms
1
Obesity
1
Inflammation
1
Hot Flashes
1
Highly Endocrine Responsive Operable Breast Cancer
1
Genetic Diseases, Inborn
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Carcinoma In Situ
1
Advanced Breast Cancer
1
Interventions
palbociclib
2
Ketorolac
2
dapagliflozin
1
Tablets
1
Surgical Procedures, Operative
1
Sulindac
1
Specimen Handling
1
Rivaroxaban
1
Resistance Training
1
Radiotherapy, Conformal
1
Probiotics
1
Pregabalin
1
Plastic Surgery Procedures
1
Omeprazole
1
Neoadjuvant Therapy
1
Methods
1
Mastectomy
1
Massage
1
Losartan
1
Ibuprofen
1
Fish Oils
1
Exercise
1
Cognitive Behavioral Therapy
1
Bevacizumab
1
Art Therapy
1
Anti-Inflammatory Agents, Non-Steroidal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Inflammation
×
Tablets
×
Breast
×
Clear all
NCT06150898
2025-06-13
KePreSt
Jules Bordet Institute
Phase 2
Recruiting
112 enrolled